X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment

Leanne M. Dibbens; Patrick Tarpey; Kim Hynes; Marta A. Bayly; Ingrid E. Scheffer; Raffaella Smith; Jamee M. Bomar; Edwina Sutton; Lucianne Vandeleur; Cheryl Shoubridge; Sarah Edkins; Samantha J. Turner; Claire Stevens; Sarah O’Meara; Calli Tofts; Syd Barthorpe; Gemma Buck; Jennifer Cole; Kelly Halliday; David Jones; Rebecca Lee; Mark Madison; Tatiana Mironenko; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; John Teague; Ed Dicks; Adam P. Butler; Andrew Menzies; Andy Jenkinson; Rebecca Shepherd; James F. Gusella; Zaid Afawi; Aziz Mazarib; Miriam Y. Neufeld; Sara Kivity; Dorit Lev; Tally Lerman‐Sagie; Amos D. Korczyn; Christopher P. Derry; Grant R. Sutherland; Kathryn Friend; Marie Shaw; Mark Corbett; Hyung‐Goo Kim; Daniel H. Geschwind; Paul Q. Thomas; Eric Haan; Stephen G. Ryan; Shane McKee; Samuel F. Berkovic; P. Andrew Futreal; Michael R. Stratton; John C. Mulley; Jozef Gécz

doi:10.1038/ng.149

X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment

Leanne M. Dibbens(Women's and Children's Hospital), Patrick Tarpey(Wellcome Sanger Institute), Kim Hynes(Women's and Children's Hospital), Marta A. Bayly(Women's and Children's Hospital), Ingrid E. Scheffer(Royal Children's Hospital), Raffaella Smith(Wellcome Sanger Institute), Jamee M. Bomar(University of California, Los Angeles), Edwina Sutton(The University of Adelaide), Lucianne Vandeleur(Women's and Children's Hospital), Cheryl Shoubridge(Women's and Children's Hospital), Sarah Edkins(Wellcome Sanger Institute), Samantha J. Turner(The University of Melbourne), Claire Stevens(Wellcome Sanger Institute), Sarah O’Meara(Wellcome Sanger Institute), Calli Tofts(Wellcome Sanger Institute), Syd Barthorpe(Wellcome Sanger Institute), Gemma Buck(Wellcome Sanger Institute), Jennifer Cole(Wellcome Sanger Institute), Kelly Halliday(Wellcome Sanger Institute), David Jones(Wellcome Sanger Institute), Rebecca Lee(Wellcome Sanger Institute), Mark Madison(Wellcome Sanger Institute), Tatiana Mironenko(Wellcome Sanger Institute), Jennifer Varian(Wellcome Sanger Institute), Sofie West(Wellcome Sanger Institute), Sara Widaa(Wellcome Sanger Institute), Paul Wray(Wellcome Sanger Institute), John Teague(Wellcome Sanger Institute), Ed Dicks(Wellcome Sanger Institute), Adam P. Butler(Wellcome Sanger Institute), Andrew Menzies(Wellcome Sanger Institute), Andy Jenkinson(Wellcome Sanger Institute), Rebecca Shepherd(Wellcome Sanger Institute), James F. Gusella(Harvard University), Zaid Afawi(Tel Aviv Sourasky Medical Center), Aziz Mazarib(Tel Aviv Sourasky Medical Center), Miriam Y. Neufeld(Tel Aviv Sourasky Medical Center), Sara Kivity(Schneider Children's Medical Center), Dorit Lev(Wolfson Medical Center), Tally Lerman‐Sagie(Wolfson Medical Center), Amos D. Korczyn(Harvard University), Christopher P. Derry(The University of Melbourne), Grant R. Sutherland(Women's and Children's Hospital), Kathryn Friend(Women's and Children's Hospital), Marie Shaw(Women's and Children's Hospital), Mark Corbett(Women's and Children's Hospital), Hyung‐Goo Kim(Harvard University), Daniel H. Geschwind(University of California, Los Angeles), Paul Q. Thomas(The University of Adelaide), Eric Haan(Women's and Children's Hospital), Stephen G. Ryan(AstraZeneca (United States)), Shane McKee(University of Ulster), Samuel F. Berkovic(The University of Melbourne), P. Andrew Futreal(Wellcome Sanger Institute), Michael R. Stratton(Wellcome Sanger Institute), John C. Mulley(Women's and Children's Hospital), Jozef Gécz(Women's and Children's Hospital)

Nature Genetics

May 11, 2008

10.1038/ng.149

Cited by 445Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis